Loading…
Reported covered position: 2008-2015, Office of Rep. Pat Tiberi - Legis. Correspondent, Legis. Assistant, Legis. Director; 2015-2016, Senate Joint Economic Committee; 2016-2017, Office of Rep. Pat Tiberi, Deputy Chief of Staff
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2019 · first_quarter · 1A
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Discussions regarding company's consumer financial services offerings
Source: Senate LDA
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Protecting Consumer Access to Generic Drugs Act of 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: WALMART INC · Firm: WALMART INC.
H.R. 2193, Remote Transactions Parity Act of 2017 S.976, the Marketplace Fairness Act of 2017 Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: WALMART INC · Firm: WALMART INC.
Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates and implementation Discussions regarding Wayfair Supreme Court Decision H.R. 6824, Online Sales Simplicity and Small Business Relief Act of 2018, and issues of collection of sales tax by remote vendors
H.R. 2193, Remote Transactions Parity Act of 2017 S.976, the Marketplace Fairness Act of 2017 Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates
Discussions regarding employee benefits innovations Discussions regarding Walmart's opioid stewardship policies Discussion regarding prescription drug price transparency Discussions regarding H.R.6, SUPPORT for Patients and Communities Act
Online Sales Simplicity and Small Business Relief Act of 2018
Client: WALMART INC · Firm: WALMART INC.
Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates and implementation Discussions regarding Wayfair Supreme Court Decision H.R. 6824, Online Sales Simplicity and Small Business Relief Act of 2018, and issues of collection of sales tax by remote vendors
Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2019
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding infrastructure proposal and funding Advocated for regulatory parity for electric trucks in House THUD appropriations bill (S.3023)
Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
H.R. 2193, Remote Transactions Parity Act of 2017 S.976, the Marketplace Fairness Act of 2017 Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates
Discussions regarding company investment in associates including workforce training initiatives, wages, benefits and future of work Discussions regarding corporate share re-purchase programs and wages Discussions regarding fair chance hiring
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2019 · second_quarter · Q2
Discussions regarding infrastructure proposal and funding
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions regarding Lower Healthcare Costs Act of 2019, S.1895 Discussions regarding reforms to DIR fees in Phair Pricing Act, H.R.1034/S.640
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding U.S.-Mexico customs issues Discussions regarding World Trade Organization negotiations NAFTA/USMCA discussions regarding passage of USMCA
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
2019 · first_quarter · 1A
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding company's consumer financial services offerings
Discussions regarding company investment in associates including workforce training initiatives and future of work Discussions regarding fair chance hiring
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2019 · first_quarter · Q1
Discussions regarding company's consumer financial services offerings
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA)
Discussions regarding Walmart's opioid stewardship initiatives Discussions regarding pharmacy provider status legislation Discussions regarding drug pricing legislation including the H.R.965, the CREATES Act, and H.R.1499, Protecting Consumers' Access to Generic Drugs Act Discussions related to prescription drug affordability Discussions regarding S.724, the John S. McCain Opioid Addiction Prevention Act
Discussions regarding company investment in associates including workforce training initiatives and future of work Discussions regarding fair chance hiring
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Q4
Treasury 965 Regulations specific to aggregate cash position
Discussions regarding employee benefits innovations Discussions regarding Walmart's opioid stewardship policies Discussion regarding prescription drug price transparency Discussions regarding H.R.6, SUPPORT for Patients and Communities Act
Discussions regarding company investment in associates including workforce development initiatives; Discussions related to associate opportunity - H.R.7145/S.3640, Stop Welfare for Any Large Monopoly Amassing Revenue from Taxpayers Act of 2018
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Maritime Commission, General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · third_quarter · Q3
Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA) Discussions regarding trade enforcement actions and tariff proposals by the Administration
Discussions regarding infrastructure proposal and funding Advocated for regulatory parity for electric trucks in House THUD appropriations bill (S.3023)
Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates and implementation Discussions regarding Wayfair Supreme Court Decision H.R. 6824, Online Sales Simplicity and Small Business Relief Act of 2018, and issues of collection of sales tax by remote vendors
2018 · second_quarter · Q2
H.R. 2193, Remote Transactions Parity Act of 2017 S.976, the Marketplace Fairness Act of 2017 Issues related to PL 115-97 (H.R. 1, Tax Cuts and Jobs Act) including investment in associates
Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA) Discussions regarding World Trade Organization negotiations Discussions regarding trade enforcement actions and tariff proposals by the Administration
Discussions regarding infrastructure proposal Discussions regarding PierPass
Filing targets: Agriculture, Dept of (USDA), Federal Maritime Commission, HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)